Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: FASEB J. 2020 Feb 17;34(4):4890–4903. doi: 10.1096/fj.201902338RR

TABLE 2.

Ligands used to develop the global ABCG2 pharmacophore model

Ko143 Lapatinib Nilotinib Vemurafenib Imatinib
Sunitinib Sorafenib Gefitinib Tariquidar Curcumin
AST-1306 WHI-P154 Apigenin Pelitinib Nobiletin
Hoechst 33342 Pheophorbide a Mitoxantrone Topotecan 4-[(2-phenylquinazolin-4-yl)amino]benzonitrile